Trading Update, Abbey PLC, 2020-05-07






RNS Number : 3089M
Abbey PLC
07 May 2020
 

 

7 May 2020

 

Abbey plc

 

Trading Update

 

 

For the year ending 30th April 2020 Abbey Plc has completed 490 house sales (UK 405, Ireland 57, Czechia 28). The comparative figures for the previous year were 579 house sales (UK 511, Ireland 36, Czechia 32).

 

Group turnover for the year was in the region of 20% lower than last year. Fixed costs together with lower margins and a very weak plant hire result mean operating profits will likely be at least in the region of 35% lower than last year.

 

Looking ahead limited production consistent with official guidance is now resuming at our UK building projects. This production is focussed on the early completion of existing work in progress. This is intended to maximise short term cash flow. For the time being no new projects are been started.

 

In Ireland production is indicated to resume on the 18th May and in Czechia, limited work has continued throughout the lockdown.

 

Forward orders across the division are in excess of 300 homes.

 

The plant hire business traded at 30% of normal levels in April.

 

The Group’s net cash position at the year end was €70 million. Aside from one payment of circa €2.3m due in the first quarter all land creditors have been paid.

 

The short term outlook is critically dependent on an early easing of the lockdown and a resumption of normal sales activity.

 

The medium term is unclear.

 

Full year results should be published in the week beginning 6th July 2020.

 

Enquires:

 

Abbey plc:                                                                           Davy:

 

David Dawson                                                                   Brian Garrahy

Tel: +44 1707 651266                                                       Tel:+353 1 679 6363

 

7 May 2020

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 

END

 
 

TSTSSSFEWESSEEI

Leave a Reply

Your email address will not be published.